BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/13/2014 7:02:00 PM | Browse: 1187 | Download: 1500
 |
Received |
|
2013-11-28 14:36 |
 |
Peer-Review Started |
|
2013-11-29 13:23 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2014-03-20 20:10 |
 |
Revised |
|
2014-04-10 19:59 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2014-07-29 08:35 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2014-07-29 09:03 |
 |
Articles in Press |
|
2014-07-29 09:03 |
 |
Edit the Manuscript by Language Editor |
|
2014-08-06 23:22 |
 |
Typeset the Manuscript |
|
2014-10-14 16:28 |
 |
Publish the Manuscript Online |
|
2014-12-13 19:01 |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Review |
| Article Title |
Transdifferentiation of pancreatic α-cells into insulin-secreting cells: From experimental models to underlying mechanisms
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jieli Lu, Rami Jaafer, Rémy Bonnavion, Philippe Bertolino and Chang-Xian Zhang |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Agence National de Recherche |
ANR 2010 BLAN 1240 01 |
| Ligue contre le Cancer du Rhône and de la Loire |
|
| CMIRA program of Region Rhône-Alpes |
12004959-01 |
| Fondation ARC pour la Recherche sur le Cancer, France |
SFI20101201530 |
| National Nature Science Foundation of China |
NSFC81170719 |
| National Nature Science Foundation of China |
81370960 |
| Shanghai New Excellent Youth Program |
XYQ2011009 |
|
| Corresponding Author |
Jieli Lu, MD, PhD, Sino-French Life Science and Genomic Center, the E-Institute of Shanghai, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University, Xuhui District, Shanghai 200025, China. jielilu@hotmail.com
|
| Key Words |
α-cell; β-cell; Transdifferentiation; Diabetes mellitus; Cell-replacement therapy |
| Core Tip |
Recent works highlighted the phenomenon of transdifferentiation of pancreatic α cells into β cells, which has drawn much attention in the field. Considering that α-cell transdifferentiation could be used as a new strategy of cell replacement therapy for the treatment of diabetes, because of the presence of α cells in the pancreas of both type 1 and 2 diabetics, we believe that it is relevant to elucidate the cellular and molecular events in α- to β-cell conversion. Our review focuses on the recent experimental α-cell transdifferentiation models, highlighting the insight provided by these works into the candidates and contexts revealed to be involved in this process.
|
| Publish Date |
2014-12-13 19:01 |
| Citation |
Lu J, Jaafer R, Bonnavion R, Bertolino P, Zhang CX. Transdifferentiation of pancreatic α-cells into insulin-secreting cells: From experimental models to underlying mechanisms. World J Diabetes 2014; 5(6): 847-853 |
| URL |
http://www.wjgnet.com/1948-9358/full/v5/i6/847.htm |
| DOI |
http://dx.doi.org/10.4239/wjd.v5.i6.847 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.